JP2023502782A5 - - Google Patents
Info
- Publication number
- JP2023502782A5 JP2023502782A5 JP2022530253A JP2022530253A JP2023502782A5 JP 2023502782 A5 JP2023502782 A5 JP 2023502782A5 JP 2022530253 A JP2022530253 A JP 2022530253A JP 2022530253 A JP2022530253 A JP 2022530253A JP 2023502782 A5 JP2023502782 A5 JP 2023502782A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939978P | 2019-11-25 | 2019-11-25 | |
| US62/939,978 | 2019-11-25 | ||
| PCT/US2020/062299 WO2021108609A1 (en) | 2019-11-25 | 2020-11-25 | Brain repair after traumatic brain injury through neurod1-mediated astrocyte-to-neuron conversion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502782A JP2023502782A (ja) | 2023-01-25 |
| JP2023502782A5 true JP2023502782A5 (https=) | 2023-12-01 |
| JPWO2021108609A5 JPWO2021108609A5 (https=) | 2023-12-01 |
Family
ID=76130727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530253A Pending JP2023502782A (ja) | 2019-11-25 | 2020-11-25 | 星状細胞からニューロンへのＮｅｕｒｏＤ１媒介性変換を介した外傷性脳損傷後の脳の修復 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4065227A4 (https=) |
| JP (1) | JP2023502782A (https=) |
| CN (1) | CN115135382A (https=) |
| AU (1) | AU2020391479A1 (https=) |
| CA (1) | CA3162891A1 (https=) |
| WO (1) | WO2021108609A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120418229A (zh) * | 2022-12-28 | 2025-08-01 | 安斯泰来制药株式会社 | 4-氨基哌啶化合物、其脂质纳米粒子和含有其的药物组合物 |
| WO2024162304A1 (ja) * | 2023-01-31 | 2024-08-08 | アステラス製薬株式会社 | 環状アミンを有するカルバモイル脂質又はウレア脂質、それを含む脂質ナノ粒子、及び医薬組成物 |
| WO2025143118A1 (ja) * | 2023-12-27 | 2025-07-03 | アステラス製薬株式会社 | 脊髄損傷の治療用医薬組成物及び脊髄損傷の非ヒト霊長類動物モデルの作製方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087168A (en) * | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
| US10561742B2 (en) * | 2012-07-19 | 2020-02-18 | The Penn State Research Foundation | Methods and compositions for treatment of disease or injury of the nervous system |
| US10076574B2 (en) * | 2013-10-25 | 2018-09-18 | Wayne State University | Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming |
| CA2903933C (en) * | 2015-09-11 | 2020-02-25 | Nomadogen Biotechnologies Inc. | Methods and compositions for the packaging of nucleic acids into microglial exosomes for the targeted expression of polypeptides in neural cells |
| US9840542B2 (en) * | 2015-09-11 | 2017-12-12 | Nomadogen Biotechnologies Inc. | Methods and compositions for the packaging of nucleic acids into microglial exosomes for the targeted expression of polypeptides in neural cells |
| US10973930B2 (en) * | 2016-02-18 | 2021-04-13 | The Penn State Research Foundation | Generating GABAergic neurons in brains |
| US20200054711A1 (en) * | 2017-02-28 | 2020-02-20 | The Penn State Research Foundation | Regenerating functional neurons for treatment of neural injury caused by disruption of blood flow |
| EP3746109A4 (en) * | 2018-02-02 | 2021-11-03 | The Penn State Research Foundation | METHODS AND MATERIALS FOR TREATING BRAIN INJURY |
-
2020
- 2020-11-25 EP EP20894844.8A patent/EP4065227A4/en not_active Withdrawn
- 2020-11-25 AU AU2020391479A patent/AU2020391479A1/en not_active Abandoned
- 2020-11-25 CA CA3162891A patent/CA3162891A1/en active Pending
- 2020-11-25 JP JP2022530253A patent/JP2023502782A/ja active Pending
- 2020-11-25 WO PCT/US2020/062299 patent/WO2021108609A1/en not_active Ceased
- 2020-11-25 CN CN202080081784.9A patent/CN115135382A/zh active Pending